Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | CETP | P11597 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | MTOR | P42345 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | UBE2N | P61088 | 1/20 | 0.55 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15057401 | 1.00 | SPHK1 (0.55) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL21428085 | 1.00 | SPHK1 (0.55) | SPHK1CYP2D6CETPLMNAGMNN | |
| Hydrochloric Acid SCHEMBL7612591 | 0.98 | SPHK1 (0.53) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL1630183 | 0.98 | SPHK1 (0.52) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL4145583 | 0.83 | LMNA (0.48) | SPHK1CYP2D6CETPLMNAGMNN | |
| Ammonia Solution, Strong SCHEMBL27688807 | 0.82 | SPHK1 (0.48) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL21636792 | 0.82 | SPHK1 (0.52) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL21428147 | 0.80 | SPHK1 (0.49) | SPHK1CYP2D6CETPLMNAGMNN | |
| Phosphoric Acid SCHEMBL10482628 | 0.79 | PTPN1 (0.50) | SPHK1CYP2D6CETPLMNAGMNN | |
| SCHEMBL10441289 | 0.77 | SPHK1 (0.54) | SPHK1CYP2D6CETPLMNAGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534439-B2 | Xanthohumol derivatives and methods for making and using | OREGON STATE UNIVERSITY (US) | 2026-01-27 | — | — | US | disclosed |
| EP-4522646-A2 | APOE LIPOPROTEIN SYSTEMS | Kisbee Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20240051922-A1 | XANTHOHUMOL DERIVATIVES AND METHODS FOR MAKING AND USING | OREGON STATE UNIVERSITY (US) | 2024-02-15 | — | — | US | disclosed |
| WO-2023220387-A2 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20210275473-A1 | SPHINGOSINE ANALOGS AND USE THEREOF AGAINST BACTERIAL LUNG INFECTIONS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-09-09 | — | — | US | disclosed |
| WO-2020016894-A1 | SPHINGOSINE ANALOGS AND USE THEREOF AGAINST BACTERIAL LUNG INFECTIONS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2020-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534439-B2 | Xanthohumol derivatives and methods for making and using | MT-CO1, MT-CO2, PC | SPHK1 4094/4885CYP2D6 357/4885CETP 850/4885 |
| US-20210275473-A1 | SPHINGOSINE ANALOGS AND USE THEREOF AGAINST BACTERIAL LUNG INFECTIONS | SPHK1, S1PR1, S1PR4 | SPHK1 1/4885CYP2D6 4585/4885CETP 505/4885 |
| US-20240051922-A1 | XANTHOHUMOL DERIVATIVES AND METHODS FOR MAKING AND USING | XDH, PC, TFB2M | SPHK1 2945/4885CYP2D6 573/4885CETP 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.